Q&A with Bjoern Peters, Ph.D.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
Reactions reflect unique features of an individual’s immune system, not the strength of a response
Antibodies can change to counter new forms of the shape-shifting virus, research hints
LA JOLLA—A team of scientists at La Jolla Institute for Immunology (LJI) has won the XPRIZE Rapid COVID Testing competition.
In addition to developing the antibodies for use in diagnostic applications based on N protein-specific antibodies, Leinco will make these antibodies commercially available as part of their extensive catalogue of research tools.
People who have already been sick with Covid-19 should still be vaccinated, experts say, but they may experience intense side effects even after one dose.
New LJI research gives detailed look at vulnerable sites on the novel coronavirus—beyond the receptor binding domain
New research highlights the enormous variability in how T cells respond to the deadly virus
To speed inoculations, the U.S. plans to release all available vaccine doses and open access to anyone over 65. Others suggest straying from recommended doses or intentionally delaying boosters. The best way forward remains uncertain.